Author:
Liu Xiang-Yang,Zhang Ning,Chen Rui,Zhao Jia-Guo,Yu Pei
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference47 articles.
1. Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: A randomized, double-blind, placebo-controlled 102-week trial;Bailey;BMC Medicine,2013
2. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: A randomised, double-blind, placebo-controlled trial;Bailey;Lancet,2010
3. Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis;Baker;Journal of the American Society of Hypertension,2014
4. Impact of sodium glucose cotransporter 2 inhibitors on weight in patients with type 2 diabetes mellitus;Barnett;Postgraduate Medicine,2013
5. Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: A randomised, double-blind, placebo-controlled trial;Barnett;The Lancet Diabetes & Endocrinology,2014
Cited by
116 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献